Abstract
In the United States, breast cancer is the commonest malignancy of women and accounts for more deaths than any other tumor (1). Nearly 100 years ago, Beatson (2) demonstrated that oophorectomy could induce remission in some women with metastatic breast cancer. This was the first clinical suggestion that breast cancer growth could be regulated by the hormone estrogen. Since that time, manipulations aimed at reducing the estrogen available to breast cancer tissues have included surgical oophorectomy, adrenalectomy and hypophysectomy. Additionally, pharmacologic agents that inhibit estrogen synthesis, estrogen binding to its receptor and pituitary releasing factor analogs have been developed. These therapies are successful in only a minority of patients with breast cancer (3). Many breast cancers are not hormonally sensitive at the time of diagnosis and most of those cancers that are initially sensitive will eventually escape their dependence on estrogen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. M. Parkin, J. Stjernsward and C. S. Muir, Estimates of the world-wide frequency of twelve major cancers, Bull. WHO. 62:163 (1984).
G. T. Beatson, On the treatment of inoperable cases of carcinoma of the mamma. Suggestions for a new method of treatment with illustrative cases, Lancet. 2:104 (1896).
I. C. Henderson, Endocrine therapy in metastatic breast cancer, in: Breast Diseases, J. R. Harris, S. Hellman, I. C. Henderson, D. W. Kinne, eds., J. B. Lippincott Co., Philadelphia, (1987).
M. E. Lippman, Definition of hormones and growth factors required for optimal proliferation and expression of phenotypic responses in human breast cancer cells, in: Cell Culture Methods for Molecular and Cell Biology, Vol.2, D. W. Barnes, D. A. Sirbasku and G. H. Sato, ed., Alan R. Liss, New York, (1984).
J. A. Eisman, T. J. Martin, I. Maclntyre, R. J. Framptin, J. M. Moseley and R. Whitehead, 1,25-dihydroxyvitamin D3 receptor in a cultured breast cancer cell line (MCF-7 cells), Biochem. Biophys. Res. Comm.. 93:9 (1980).
M. B. Sporn and A. B. Roberts, Autocrine growth factors and cancer, Nature. 313:745 (1985).
C. K. Osborne, G. Bolan, M. E. Monaco and M. E. Lippman, Hormone responsive human breast cancer in long-term tissue culture: effect of insulin, Proc. Natl. Acad. Sci.. 73:4536 (1976).
R. W. Furlanetto and J. N. DiCarlo, Somatomedin-C receptors and growth effects in human breast cells maintained in long term tissue culture, Canc. Res.. 44:2122 (1984).
J. S. Flier, P. Usher and A. C. Moses, Monoclonal antibody to the type I insulinlike growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts, Proc. Natl. Acad. Sci.. 83:664 (1986).
K. K. Huff, D. Kaufman, K. H. Gabbay, E. M. Spencer, M. E. Lippman and R. B. Dickson, Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells, Canc. Res.. 46:4613 (1986).
Y. Myal, R. P. C. Shiu, B. Bhaumick and M. Bala, Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture, Canc. Res.. 44:5486 (1984).
D. Yee, K. J. Cullen, S. Paik, J. F. Perdue, B. Hampton, A. Schwartz, M.E. Lippman and N. Rosen, Insulin-like growth factor II mRNA expression in human breast cancer, Canc. Res.. 48:6691 (1988).
K. P. Karey and D. A. Sirbasku, Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol, Canc. Res.. 48:4083 (1988).
P. E. Cryer, Glucose homeostasis and hypoglycemia, in: Williams Textbook of Endocrinology, J. D. Wilson and D. W. Foster, eds. W.B. Saunders Co., Philadelphia (1985).
V. K. M. Han, A. J. D’Ercole and P. K. Lund, Cellular localization of somatomedin messenger RNA in the human fetus, Science. 236:193 (1987).
F. Minuto, P. DelMonte, A. Barreca, A. Nicolin and G. Giordano, Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro, Mol. Cell. Endo.. 54:179 (1987).
C. K. Osborne, C. R. Ross, E. B. Coronado, S. A. Fuqua and L. J. Kitten, Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model, Breast Canc. Res. Treat.. 11:211 (1988).
D. Yee, S. Paik, G. S. Lebovic, R. R. Marcus, R. E. Favoni, K. J. Cullen, M. E. Lippman, and N. Rosen, Analysis of IGF-I gene expression in malignancy, evidence for a paracrine role in human breast cancer, Mol. Endo., in press (1989).
P. Rotwein, K. M. Pollock, N. Watson and D. T. Milbrandt, Insulin-like growth factor gene expression during rat embryonic development, Endo.. 121:2141 (1987).
R. Peres, C. Betsholtz, B. Westermark and C.-H. Heldin, Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines, Canc. Res.. 47:3425 (1987).
M. Binoux, P. Hossenlopp, S. Hardouin, D. Seurin, C. Lassarre and M. Gourmelen, Somatomedin (insulin-like growth factors)-binding proteins, molecular forms and regulation, Hormone Res.. 24:141 (1986).
W. H. Daughaday, M. Kapadia and I. Mariz, Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay, J. Lab. Clin. Med.. 109:355 (1987).
D. De Leon, B. Bakker, D. M. Wilson, R. L. Hintz and R. G. Rosenfeld, Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines, Biochem. Biophys. Res. Comm.. 152:398 (1988).
D. Yee, R. E. Favoni, R. Lupu, K. J. Cullen, G. S. Lebovic, K. K. Huff, P. D. K. Lee, Y. L. Lee, D. R. Powell, R. B. Dickson, N. Rosen, and M. E. Lippman, The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells, Biochem. Biophys. Res. Comm.. in press, (1989)
Y.-L. Lee, R. L. Hintz, P. M. James, P. D. K. Lee, J. E. Shively and D. R. Powell, Insulin-like growth factor (IGF) binding protein cDNA from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors, Mol. Endo.. 2:404 (1988).
A. Brinkman, C. Groffen, D. J. Kortleve, A. Geurts van Kessel and S. L. S. Drop, Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1), EMBO J., 7:2417 (1988).
W. H. Busby Jr., D. G. Klapper and D. R. Clemmons, Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid, isolation of two forms with different biological actions, J. Biol. Chem.. 26:14203 (1988).
J.-P. Peyrat, J. Bonneterre, J. Beuscart, J. Dijane and A. Demaille, Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors, Canc. Res.. 48:6429 (1988).
Q. T. Rohlik, D. Adams, F. C. Kull Jr. and S. Jacobs, An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture, Biochem. Biophys. Res. Comm.. 149:276 (1987).
R. A. Roth, Structure of the receptor for insulin-like growth factor II: the puzzle amplified, Science. 239:1269 (1988).
C. L. Arteaga, L. Kitten, E. Coronado, S. Jacobs, F. Kull and C. K. Osborne, Blockade of the type I somatomedin receptor inhibits growth of estrogen receptor negative human breast cancer cells in athymic mice, Proc. Endo. Soc. 70th Annual Meeting. A683 (1988).
D. R. Clemmons and J. J. Van Wyk, Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells, J. Clin. Invest.. 75:1914 (1985).
D. A. Bronzert, P. Pantazis, H. N. Antoniades, A. Kasid, N. Davidson, R. B. Dickson, and M. E. Lippman, Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines, Proc. Natl. Acad. Sci.. 84:5763 (1987).
D. R. Clemmons, Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts, J. Clin. Endo. Metab.. 58:850 (1984).
P. de Pagter-Holthuizen, M. Jansen, F. M. A. van Schaik, R. vanderKammen, C. Oosterwijk, J. L. Van den Brande, and J. S. Sussenbach, The human insulin-like growth factor II gene contains two development-specific promoters, FEBS letters. 214:259 (1987).
M. T. Travers, P. J. Barrett-Lee, U. Berger, Y. A. Luqmani, J.-C. Gazet, T. J. Powles, and R. C. Coombes, Growth factor expression in normal, benign, and malignant breast tissue, Br. Med. J.. 296:1621 (1988).
J. Scott, J. Cowell, M. E. Robertson, L. M. Priestley, R. Wadey, B. Hopkins, J. Pritchard, G. I. Bell, L. B. Rail, C. F. Graham, and T. J. Knott, Insulinlike growth factor-II gene expression in Wilms’tumour and embryonic tissues, Nature. 317:260 (1985).
A. E. Reeve, M. R. Eccles, R. J. Wilkins, G. I. Bell and L. J. Millow, Expression of insulin-like growth factor-II transcripts in Wilms’ tumour, Nature. 317:258 (1985).
K. Ramasharma and C. H. Li, Human pituitary and placental hormones control human insulin-like growth factor II secretion in human granulosa cells, Proc. Natl. Acad. Sci.. 84:2643 (1987).
R. P. C. Shiu, L. C. Murphy, Y. Myal, T. C. Dembinski, D. Tsuyuki and B. M. Iwasiow, Actions of pituitary prolactin and insulin-like growth factor II in human breast cancer, in: Breast Cancer: Cellular and Molecular Biology, M.E. Lippman, R.B. Dickson, eds. Kluwer Academic Publishers, Boston, (1988).
C. B. Newman, H. Cosby, H. G. Friesen, M. Feldman, P. Cooper, V. DeCrescito, M. Pilon, and D. L. Kleinberg, Evidence for a nonprolactin, non-growth-hormone mammary mitogen in the human pituitary gland, Proc. Natl. Acad. Sci.. 84:8110 (1987).
I. Ali, R. Lidereau, C. Theillet, R. Callahan, Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia, Science. 238:185 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Yee, D., Cullen, K.J., Paik, S., Lippman, M.E., Rosen, N. (1989). Growth Regulation of Human Breast Cancer by Insulin-Like Growth Factors. In: LeRoith, D., Raizada, M.K. (eds) Molecular and Cellular Biology of Insulin-like Growth Factors and Their Receptors. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5685-1_21
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5685-1_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5687-5
Online ISBN: 978-1-4684-5685-1
eBook Packages: Springer Book Archive